九洲药业(603456) - 2017 Q1 - 季度财报

Financial Performance - Operating revenue rose by 12.40% to CNY 394,550,338.01 year-on-year[4] - Net profit attributable to shareholders increased by 11.41% to CNY 42,200,219.85 compared to the same period last year[4] - Basic earnings per share rose by 11.11% to CNY 0.10 per share[4] - Total operating revenue for Q1 2017 was CNY 394,550,338.01, an increase of 12.4% compared to CNY 351,026,569.40 in the same period last year[27] - Net profit attributable to the parent company for Q1 2017 was CNY 45,880,460.20, representing a growth of 14.5% compared to CNY 40,073,118.00 in Q1 2016[27] - The total comprehensive income for Q1 2017 was CNY 10,298,741.85, significantly lower than CNY 49,328,443.16 in the same period last year[30] Cash Flow - Net cash flow from operating activities decreased by 43.25% to CNY 68,134,690.28 compared to the previous year[4] - Cash flow from operating activities decreased by 43.25% to ¥68,134,690.28 from ¥120,070,693.37, mainly due to increased acceptance settlement business[13] - The net cash flow from operating activities for Q1 2017 was CNY 68,134,690.28, a decrease of 43% from CNY 120,070,693.37 in Q1 2016[33] - Total cash inflow from operating activities was ¥378,933,508.83, slightly down from ¥385,954,363.83 year-over-year[36] - The net cash flow from investing activities was -¥13,828,232.83, an improvement from -¥66,170,063.28 in the previous period[37] - The net cash flow from financing activities was ¥49,982,184.71, a significant recovery from -¥86,956,372.24 in the previous period[37] Assets and Liabilities - Total assets increased by 3.84% to CNY 3,113,922,550.53 compared to the end of the previous year[4] - The total assets increased to ¥3,113,922,550.53 from ¥2,998,806,634.32, reflecting overall growth in the company's financial position[19] - The total liabilities increased to ¥467,834,990.23 from ¥397,928,341.20, indicating a rise in the company's financial obligations[19] - Total liabilities as of March 31, 2017, were CNY 317,001,228.02, compared to CNY 250,298,231.00 at the start of the year, reflecting a rise of 26.5%[24] Shareholder Information - The total number of shareholders reached 21,614 at the end of the reporting period[9] - Zhejiang Zhongbei Jiuzhou Group Co., Ltd. held 44.43% of the shares, with 97,500,000 shares pledged[9] Other Financial Metrics - The weighted average return on equity increased by 0.14 percentage points to 1.63%[4] - Non-recurring gains and losses totaled CNY 2,590,733.49 for the period[7] - The company received government subsidies amounting to CNY 3,060,087.46 during the reporting period[6] - Cash and cash equivalents increased by 44.67% to ¥374,114,545.14 from ¥258,603,036.86, primarily due to bank loans received[11] - Other receivables decreased by 48.06% to ¥5,812,494.18 from ¥11,190,628.09, mainly due to the recovery of part of the financing deposit by a subsidiary[11] - Intangible assets rose by 36.73% to ¥210,880,631.96 from ¥154,231,830.51, attributed to the acquisition of land use rights by a subsidiary[11] - Short-term borrowings surged by 91,295.80% to ¥91,395,800.00 from ¥100,000.00, mainly due to increased bank loans[12] - Employee compensation payable decreased by 45.67% to ¥23,292,429.52 from ¥42,869,252.16, primarily due to year-end bonuses paid in the previous year[12] - Tax payable increased by 95.36% to ¥28,485,760.20 from ¥14,581,059.44, mainly due to an increase in value-added tax payable[12]